Infectious Diseases

Travellers to Central and South America warned of infection and possible association with microcephaly in newborns.

Labelling will be updated to stress urgent need for care if patients experience vision problems during or after therapy.

Cephalosporin-resistant strains decline, but resistance to azithromycin increases.

Oral amoxicillin or IV ampicillin still best empiric therapy for majority of cases.

Over the past five years, the treatment of chronic hepatitis C virus (HCV) infection has changed dramatically with the development of direct-acting antiviral (DAA) agents that target various phases of the HCV lifecycle. This article outlines the current pharmacological management of HCV infection, with a focus on first-line genotype 1 treatment options.

Health Canada concludes that the vaccine’s benefits continue to outweigh the risks.